Patents for C07K 17 - Carrier-bound or immobilised peptides; Preparation thereof (10,673) |
---|
02/19/2013 | CA2560981C Polymer-based sustained release device |
02/14/2013 | US20130041141 Fluorescent polymer composition |
02/14/2013 | US20130041135 Filler for affinity chromatography and method for isolating immunoglobulin |
02/14/2013 | US20130041133 Novel single chemical entities and methods for delivery of oligonucleotides |
02/14/2013 | US20130040861 Novel methods of constructing libraries comprising displayed and/or expressed members of a diverse family of peptides, polypeptides or proteins and the novel libraries |
02/14/2013 | US20130040857 Mass spectrometric assays for peptides |
02/14/2013 | US20130040322 Method of Diagnosing Sjogren's Disease |
02/14/2013 | US20130039948 Inhibition of TCR Signaling with Peptide Variants |
02/14/2013 | US20130039939 Lipopeptide- and lipoprotein-conjugates and its use |
02/14/2013 | US20130039931 Antibodies Against A Cancer-Associated Epitope of Variant HNRNPG and Uses Thereof |
02/14/2013 | US20130039914 Novel human genes relating to respiratory diseases and obesity |
02/14/2013 | CA2844668A1 Methods and compositions for the treatment of autoimmune and inflammatory diseases |
02/14/2013 | CA2843837A1 Methods and compositions for improving sperm functionality |
02/13/2013 | EP2557091A1 PP1 ligands |
02/12/2013 | US8372963 RSV F-protein and its use |
02/12/2013 | US8372959 Production of recombinant proteins by autoproteolytic cleavage of a fusion protein |
02/12/2013 | US8372953 Composition comprising various proteorhodopsins and/or bacteriorhodopsins and use thereof |
02/12/2013 | US8372800 Albumin-free factor VIII formulations |
02/07/2013 | WO2013018880A1 Novel modified protein comprising tandem-type multimer of mutant extracellular domain of protein g |
02/07/2013 | WO2012154735A3 Thermostable carbonic anhydrases and methods of use thereof |
02/07/2013 | US20130034893 Methods for Coupling of Molecules to Metal/Metal Oxide Surfaces |
02/07/2013 | US20130034866 Multisignal reagents for labeling analytes |
02/07/2013 | US20130034854 Antibody-Nanoparticle Conjugates and Methods for Making and Using Such Conjugates |
02/07/2013 | US20130034573 Vaccine compositions |
02/07/2013 | US20130034572 Compositions and methods for brain delivery of analgesic peptides |
02/07/2013 | US20130034566 Anti-cdh3 antibodies and uses thereof |
02/06/2013 | CN102918064A A method for immobilizing streptavidin on a self-assembled monolayer |
02/06/2013 | CN102911348A Polyester/polyethyleneglycol block copolymer containing hydroxyl pendant group and application of polyester/polyethyleneglycol block copolymer |
02/06/2013 | CN101035439B Sequential protein isolation and purification schemes by affinity chromatography |
02/05/2013 | US8367809 Composite materials comprising supported porous gels containing reactive functional groups |
02/05/2013 | US8367804 High affinity NY-ESO T cell receptors |
02/05/2013 | US8367801 Proteinaceous compounds |
02/05/2013 | US8367607 Oxyntomodulin peptide analogue |
02/05/2013 | US8367070 Modified surface antigen |
02/05/2013 | US8367065 Targeted polymeric prodrugs containing multifunctional linkers |
02/05/2013 | CA2472265C Immunogenic formulations of variable peptidic epitopes and process for preparation thereof |
01/31/2013 | US20130029960 Enhanced bone healing |
01/31/2013 | US20130029868 Methods and kits for the detection of cancer infiltration of the central nervous system |
01/31/2013 | US20130029428 Preparation method of antigen-immobilized immuno- fluorescence slide and immuno-fluoroscence slide prepared thereby |
01/31/2013 | US20130028941 Synthetic nanocarriers that generate humoral and cytotoxic t lymphocyte (ctl) immune responses |
01/31/2013 | US20130028901 Novel receptor trem (triggering receptor expressed on myeloid cells) and uses thereof |
01/29/2013 | US8362214 Antibodies that bind human dendritic and epithelial cell 205 (DEC-205) |
01/29/2013 | US8362208 Immunoglobulins |
01/29/2013 | US8361740 Peptide standards |
01/29/2013 | US8361479 Promiscuous PAP CD4 T cell epitopes |
01/29/2013 | CA2462113C Multi-chain eukaryotic display vectors and uses thereof |
01/24/2013 | WO2013010225A1 Enzymes for degrading organophosphates |
01/24/2013 | US20130023444 Color-producing diagnostic systems, reagents and methods |
01/24/2013 | US20130023059 Method for immobilizing streptavidin on a self-assembled monolayer |
01/24/2013 | US20130022551 DEspR ANTAGONISTS AND AGONISTS AS THERAPEUTICS |
01/24/2013 | US20130022544 Immunotherapeutic modulation of amyloidogenic disease using non-fibrillogenic, non-amyloidogenic polymerized proteins and peptides |
01/24/2013 | US20130020526 Water-Soluble Nanoparticles Stabilized with Multi-Functional Group Ligands and Method of Preparation Thereof |
01/23/2013 | CN102892885A Iga-binding peptide and iga purification using same |
01/23/2013 | CN102892753A Chemical reagents for the activation of polysaccharides in the preparation of conjugate vaccines |
01/23/2013 | CN102295704B Method for enhancing immunogenicity of micromolecular organic matter |
01/22/2013 | US8357789 comprising an RNA sequence capable of specifically binding a polypeptide participating in influenza virus infection of cells |
01/22/2013 | US8357774 Polypeptide and process for producing the same |
01/17/2013 | US20130017251 Antibody Specific for Apolipoprotein and Methods of Use Thereof |
01/16/2013 | CN101497671B 羟烷基淀粉衍生物 Hydroxyalkyl starch derivative |
01/15/2013 | US8354507 humanized monoclonal antibodies; complementarity determining region of murine monoclonal antibody heavy chain variable domain operably fused to human heavy chain framework domain; induce apoptosis in HLA-DR-expressing tumor cells |
01/15/2013 | US8354372 Cyclised alpha-conotoxin peptides |
01/15/2013 | US8354247 Glycoprotein synthesis and remodeling by enzymatic transglycosylation |
01/15/2013 | CA2489186C Chemical synthesis of reagents for peptide coupling |
01/10/2013 | WO2012142362A3 Synthetic platelets |
01/10/2013 | WO2012141554A3 Complex in which an anti-cotinine antibody is bound to a binder material of cotinine and a binding substance, and a use therefor |
01/09/2013 | CN101636411B Interferon alpha 2a modified by polyethylene glycol, synthesis process and application thereof |
01/09/2013 | CN101160133B Preparation and composition of inter-alpha inhibitor proteins from human plasma for therapeutic use |
01/08/2013 | US8349805 Use of Gonadorelin as a therapeutic agent |
01/08/2013 | US8349800 Von Willebrand factor- and factor VIII-polymer conjugates having a releasable linkage |
01/08/2013 | US8349791 Polypeptides that bind membrane proteins |
01/08/2013 | US8349334 Molecule |
01/08/2013 | CA2572671C Cytoxan antibodies and immunoassay |
01/08/2013 | CA2466027C Branched polymers and their conjugates |
01/03/2013 | WO2013002449A1 Epitope and its use of hepatitis b virus surface antigen |
01/03/2013 | US20130005945 Forming porous scaffold from cellulose derivatives |
01/03/2013 | US20130004980 Two-way, portable riboswitch mediated gene expression control device |
01/03/2013 | US20130004522 Phototriggered nanoparticles for cell and tissue targeting |
01/03/2013 | CA2839668A1 Epitope and its use of hepatitis b virus surface antigen |
01/01/2013 | US8344102 Nanoparticle and magnetic resonance imaging contrast agent |
01/01/2013 | US8344100 Poly-epitope peptide derived from thymidylate synthase having immunological and anti-tumour activity |
01/01/2013 | US8343507 Protein from Photobacterium damselae and use thereof |
01/01/2013 | US8343503 Contiguous overlapping peptides for treatment of birch pollen allergy |
01/01/2013 | US8343500 Peptide composition |
01/01/2013 | US8343496 Anti-CD74 immunoconjugates and methods |
12/27/2012 | WO2012177775A1 Reagents and methods for bispecific antibody-based binding of target molecules |
12/27/2012 | US20120329998 Luminescent gold nanoparticle functionalized by n-(4-aminobutyl)-n-ethylisoluminol, preparation and application thereof |
12/27/2012 | US20120329708 Glucagon/glp-1 receptor co-agonists |
12/27/2012 | US20120329707 Glucagon/glp-1 receptor co-agonists |
12/27/2012 | US20120329127 Therapeutic proteins with increased half-life and methods of preparing same |
12/27/2012 | US20120328632 Inhibition of leukocyte adhesion |
12/27/2012 | DE102009021681B4 Verwendung von Staphylococcus aureus bindenden Peptiden, Verfahren und Kits zur Anreicherung, Immobilisierung und zum Nachweis von Staphylococcus aureus, Staphylococcus aureus bindendes Peptid und dafür kodierende Nukleinsäure Use of Staphylococcus aureus binding peptides, methods and kits for the enrichment, immobilization and detection of Staphylococcus aureus, Staphylococcus aureus binding peptide and nucleic acid coding therefor |
12/27/2012 | CA2876588A1 Reagents and methods for bispecific antibody-based binding of target molecules |
12/26/2012 | CN102838678A 重组促红细胞生成素及制备方法 Recombinant erythropoietin and preparation methods |
12/26/2012 | CN102838677A 重组促红细胞生成素及制备方法 Recombinant erythropoietin and preparation methods |
12/26/2012 | CN102838671A Growth hormone with site-specific mutagenesis and site-specific decoration, preparation method and applications of growth hormone |
12/25/2012 | US8340951 Synthetic enzymes derived from computational design |
12/25/2012 | US8338380 Use of the peptide RFMWMR as a therapeutic agent |
12/25/2012 | US8338366 Bioactive FUS1 peptides and nanoparticle-polypeptide complexes |
12/25/2012 | US8338364 Peptide tyrosinase inhibitors and uses thereof |
12/25/2012 | US8338180 Using virion infectivity factor (VIF) activity as diagnostic tool in screening viricidal activity of compounds |